A61K 33/00 (20130101)
The invention concerns methods and compositions for treating a neuropsychiatric disorder, wherein the method comprises administering an effective amount of a co-crystal of lithium to a subject in need thereof, wherein the co-crystal comprises lithium, or a pharmaceutically acceptable salt thereof, and an amino acid.
Tan, Jun; Smith, Adam J.; and Shytle, Roland D., "Lithium co-crystals and an additional neuropsychiatric agent for treatment of neuropsychiatric disorders" (2017). USF Patents. 920.
University of South Florida